Gwynant Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Gwynant Therapeutics General Information

Description

Operator of a drug discovery company intended to focus on developing treatments for cancer and immunological disorders. The company discovers and develops small-molecule drugs that target difficult-to-treat cancers and immunological conditions with currently unmet medical needs, enabling doctors to treat patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gwynant Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 14-Sep-2021 Completed Startup
To view Gwynant Therapeutics’s complete valuation and funding history, request access »

Gwynant Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
i2020 Accelerator Accelerator/Incubator Minority
To view Gwynant Therapeutics’s complete investors history, request access »

Gwynant Therapeutics FAQs

  • When was Gwynant Therapeutics founded?

    Gwynant Therapeutics was founded in 2021.

  • Where is Gwynant Therapeutics headquartered?

    Gwynant Therapeutics is headquartered in United Kingdom.

  • What industry is Gwynant Therapeutics in?

    Gwynant Therapeutics’s primary industry is Drug Discovery.

  • Is Gwynant Therapeutics a private or public company?

    Gwynant Therapeutics is a Private company.

  • What is Gwynant Therapeutics’s current revenue?

    The current revenue for Gwynant Therapeutics is .

  • Who are Gwynant Therapeutics’s investors?

    i2020 Accelerator has invested in Gwynant Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process